Literature DB >> 2573831

Expression of a human multidrug resistance cDNA (MDR1) in the bone marrow of transgenic mice: resistance to daunomycin-induced leukopenia.

H Galski1, M Sullivan, M C Willingham, K V Chin, M M Gottesman, I Pastan, G T Merlino.   

Abstract

The human multidrug resistance gene (MDR1) encodes a drug efflux pump glycoprotein (P-glycoprotein) responsible for resistance to multiple cytotoxic drugs. A plasmid carrying a human MDR1 cDNA under the control of a chicken beta-actin promoter was used to generate transgenic mice in which the transgene was mainly expressed in bone marrow and spleen. Immunofluorescence localization studies showed that P-glycoprotein was present on bone marrow cells. Furthermore, leukocyte counts of the transgenic mice treated with daunomycin did not fall, indicating that their bone marrow was resistant to the cytotoxic effect of the drug. Since bone marrow suppression is a major limitation to chemotherapy, these transgenic mice should serve as a model to determine whether higher doses of drugs can cure previously unresponsive cancers.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2573831      PMCID: PMC362516          DOI: 10.1128/mcb.9.10.4357-4363.1989

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  44 in total

1.  Differential degradation of messenger RNAs in mammalian cells.

Authors:  C D Stiles; K L Lee; F T Kenney
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

2.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

3.  A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants.

Authors:  R L Juliano; V Ling
Journal:  Biochim Biophys Acta       Date:  1976-11-11

4.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

5.  The human multidrug resistance (mdr1) gene. cDNA cloning and transcription initiation.

Authors:  K Ueda; D P Clark; C J Chen; I B Roninson; M M Gottesman; I Pastan
Journal:  J Biol Chem       Date:  1987-01-15       Impact factor: 5.157

6.  Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies.

Authors:  J L Biedler; H Riehm
Journal:  Cancer Res       Date:  1970-04       Impact factor: 12.701

7.  Altered surface membrane glycoproteins in Vinca alkaloid-resistant human leukemic lymphoblasts.

Authors:  W T Beck; T J Mueller; L R Tanzer
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

Review 8.  Toxicology of daunorubicin in animals and man.

Authors:  R J Maral; M Jouanne
Journal:  Cancer Treat Rep       Date:  1981

9.  Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines.

Authors:  J R Riordan; K Deuchars; N Kartner; N Alon; J Trent; V Ling
Journal:  Nature       Date:  1985 Aug 29-Sep 4       Impact factor: 49.962

10.  Isolation and genetic characterization of human KB cell lines resistant to multiple drugs.

Authors:  S Akiyama; A Fojo; J A Hanover; I Pastan; M M Gottesman
Journal:  Somat Cell Mol Genet       Date:  1985-03
View more
  21 in total

Review 1.  Hematopoietic stem cell gene therapy.

Authors:  David W Emery; Tamon Nishino; Ken Murata; Michalis Fragkos; George Stamatoyannopoulos
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

2.  Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique.

Authors:  G F Greene; Y Kitadai; C A Pettaway; A C von Eschenbach; C D Bucana; I J Fidler
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

3.  Multiparametric in situ mRNA hybridization analysis to predict disease recurrence in patients with colon carcinoma.

Authors:  Y Kitadai; L M Ellis; S L Tucker; G F Greene; C D Bucana; K R Cleary; Y Takahashi; E Tahara; I J Fidler
Journal:  Am J Pathol       Date:  1996-11       Impact factor: 4.307

Review 4.  Genetic basis of multidrug resistance of tumor cells.

Authors:  S E Kane; I Pastan; M M Gottesman
Journal:  J Bioenerg Biomembr       Date:  1990-08       Impact factor: 2.945

Review 5.  Chemoprotection of normal tissues by transfer of drug resistance genes.

Authors:  J A Rafferty; I Hickson; N Chinnasamy; L S Lashford; G P Margison; T M Dexter; L J Fairbairn
Journal:  Cancer Metastasis Rev       Date:  1996-09       Impact factor: 9.264

6.  Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance.

Authors:  G H Mickisch; G T Merlino; H Galski; M M Gottesman; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-01-15       Impact factor: 11.205

Review 7.  MDR gene transfer into live mice.

Authors:  C Richardson; M Ward; A Bank
Journal:  J Mol Med (Berl)       Date:  1995-04       Impact factor: 4.599

8.  In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells.

Authors:  Y Kitadai; C D Bucana; L M Ellis; H Anzai; E Tahara; I J Fidler
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

9.  Transfer and expression of the human multiple drug resistance gene into live mice.

Authors:  S Podda; M Ward; A Himelstein; C Richardson; E de la Flor-Weiss; L Smith; M Gottesman; I Pastan; A Bank
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

10.  P-glycoprotein-dependent resistance of cancer cells toward the extrinsic TRAIL apoptosis signaling pathway.

Authors:  Hanan Galski; Tamar Oved-Gelber; Masha Simanovsky; Philip Lazarovici; Michael M Gottesman; Arnon Nagler
Journal:  Biochem Pharmacol       Date:  2013-06-14       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.